MSB 1.32% 93.3¢ mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-206

  1. 1,095 Posts.
    lightbulb Created with Sketch. 346
    Can I get confirmation of the definite start of the 'clock' of the submission review period please?

    It's upon acceptance yes?

    So 23rd July.

    2 months takes it to 23rd September.

    So the window for approval / disaster is between September 24th and 23rd January 2025.

    Based on previous examples, the FOMO period should start to ramp up (if there is one biggrin.png ) mid October to mid November if the smarties on here are correct and we are looking at 3-4 months.


    Could be a tough 7 weeks or so, but after that, I'd expect the SP to elevate in advance of the FDA decision.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
93.3¢
Change
-0.013(1.32%)
Mkt cap ! $1.050B
Open High Low Value Volume
93.0¢ 93.5¢ 92.0¢ $1.725M 1.862M

Buyers (Bids)

No. Vol. Price($)
15 49394 93.0¢
 

Sellers (Offers)

Price($) Vol. No.
93.5¢ 112445 27
View Market Depth
Last trade - 15.19pm 09/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.